Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006.
暂无分享,去创建一个
Heinrich R Schelbert | Johannes Czernin | Martin Allen-Auerbach | H. Schelbert | J. Czernin | M. Allen-Auerbach
[1] Ora Israel,et al. The additional value of PET/CT over PET in FDG imaging of oesophageal cancer , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[2] W. De Wever,et al. Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT , 2006, European Radiology.
[3] M. Schäfer,et al. Positron Emission Tomography/Computed Tomography Influences on the Management of Resectable Pancreatic Cancer and Its Cost-Effectiveness , 2005, Annals of surgery.
[4] A. Kuten,et al. Fluorodeoxyglucose‐Positron Emission Tomography/Computed Tomography Imaging in Patients with Carcinoma of the Larynx: Diagnostic Accuracy and Impact on Clinical Management , 2006, The Laryngoscope.
[5] Mithat Gonen,et al. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. , 2004, Radiology.
[6] Gerald Antoch,et al. Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] E. Fishman,et al. Incremental value of CT in PET/CT of patients with colorectal carcinoma , 2004, Abdominal Imaging.
[8] Thomas Beyer,et al. FDG-PET/CT in re-staging of patients with lymphoma , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[9] C. Meltzer,et al. The use of Combined PET/CT for Localizing Recurrent Head and Neck Cancer: The Pittsburgh Experience , 2005, Ear, nose, & throat journal.
[10] G. V. von Schulthess,et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.
[11] M. Spieth,et al. A tabulated summary of the FDG PET literature. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] W. Jochum,et al. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. , 2006, Journal of hepatology.
[13] Sumit K. Shah,et al. Pulmonary nodule characterization: a comparison of conventional with quantitative and visual semi-quantitative analyses using contrast enhancement maps. , 2006, European journal of radiology.
[14] E. Hauth,et al. Evaluation of integrated whole-body PET/CT in the detection of recurrent ovarian cancer. , 2005, European journal of radiology.
[15] Paul Kinahan,et al. A combined PET/CT scanner for clinical oncology. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] H. Libshitz,et al. Roentgenographic evaluation of mediastinal nodes for preoperative assessment in lung cancer. , 1985, Chest.
[17] Z. Keidar,et al. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] R L Wahl,et al. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT. , 1999, Radiology.
[19] R. Tiling,et al. Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin’s disease and non-Hodgkin’s lymphoma , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[20] D. Visvikis,et al. Impact of combined 18F-FDG PET/CT in head and neck tumours , 2005, British Journal of Cancer.
[21] M. Reiser,et al. 18F-FDG PET/CT for staging of penile cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] Jinming Yu,et al. Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] F. Fazio,et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. , 2006, Radiology.
[24] Yuji Nakamoto,et al. Direct comparison of FDG PET and CT findings in patients with lymphoma: initial experience. , 2005, Radiology.
[25] Yen-Kung Chen,et al. Clinical usefulness of fused PET/CT compared with PET alone or CT alone in nasopharyngeal carcinoma patients. , 2006, Anticancer research.
[26] S. Marnitz,et al. Value of 18F-Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography in Non–Small-Cell Lung Cancer for Prediction of Pathologic Response and Times to Relapse after Neoadjuvant Chemoradiotherapy , 2006, Clinical Cancer Research.
[27] J Nuyts,et al. 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). , 2003, European journal of cancer.
[28] C. Snyderman,et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? , 2005, Radiology.
[29] R. Wahl,et al. Initial experience with FDG-PET/CT in the evaluation of breast cancer , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[30] Michael E Phelps,et al. Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. , 2005, Chest.
[31] O. Belohlávek,et al. The role of FDG-PET/CT in the detection of recurrent colorectal cancer , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[32] K. Nackaerts,et al. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lu , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] P. Schnyder,et al. The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[34] Thomas F Hany,et al. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT? , 2004, Radiology.
[35] Byung-Tae Kim,et al. Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CT. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[36] A. Figer,et al. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. , 2004, Radiology.
[37] J. Debatin,et al. Unknown primary tumors: detection with dual-modality PET/CT--initial experience. , 2005, Radiology.
[38] Y. Erdi,et al. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[39] A. Pecking,et al. Incidental colonic focal lesions detected by FDG PET/CT. , 2005, AJR. American journal of roentgenology.
[40] Thomas Beyer,et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. , 2003, Radiology.
[41] E. Nitzsche,et al. Evaluation of positron emission tomography with 2‐[18F]fluoro‐2‐deoxy‐D‐glucose for the differentiation of chronic pancreatitis and pancreatic cancer , 1999, The British journal of surgery.
[42] Holger Moch,et al. Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] C. Nanni,et al. Role of 18F-FDG PET–CT imaging for the detection of an unknown primary tumour: preliminary results in 21 patients , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[44] Byung-Tae Kim,et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. , 2005, Radiology.
[45] R. Wahl,et al. Direct Comparison of 18F-FDG PET and PET/CT in Patients with Colorectal Carcinoma , 2003 .
[46] E. Hoffman,et al. Application of annihilation coincidence detection to transaxial reconstruction tomography. , 1975, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[47] D K Owens,et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. , 2001, JAMA.
[48] R. Cerfolio,et al. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study. , 2006, The Journal of thoracic and cardiovascular surgery.
[49] Osman Ratib,et al. Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma. , 2004, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.
[50] E. Wardelmann,et al. Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[51] Otto S Hoekstra,et al. Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[52] P. Clavien,et al. Does the Novel PET/CT Imaging Modality Impact on the Treatment of Patients With Metastatic Colorectal Cancer of the Liver? , 2004, Annals of surgery.
[53] F. Fazio,et al. Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologic findings. , 2004, Radiology.
[54] J. Bucerius,et al. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[55] P. Conti,et al. 2-Deoxy-2-[F-18]Fluoro-d-Glucose–Positron Emission Tomography/Computed Tomography Imaging Evaluation of Esophageal Cancer , 2006, Molecular Imaging and Biology.
[56] A. Iagaru,et al. 18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas , 2006, Nuclear medicine communications.
[57] M. Phelps,et al. Performance of 2-Deoxy-2-[F-18]fluoro-d-glucose Positron Emission Tomography and Integrated PET/CT in Restaged Breast Cancer Patients , 2005, Molecular Imaging and Biology.
[58] Osman Ratib,et al. Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[59] David Goldenberg,et al. The Role of Positron Emission Tomography/Computed Tomography in the Management of Recurrent Papillary Thyroid Carcinoma , 2005, The Laryngoscope.
[60] Ora Israel,et al. Cancer Recurrence: Diagnostic Value and Impact on Patient Management , 2004 .
[61] T. Hany,et al. Bone involvement in patients with lymphoma: the role of FDG-PET/CT , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[62] R. Wahl,et al. Clinically significant incidental findings on the unenhanced CT portion of PET/CT studies: frequency in 250 patients. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[63] Richard L Wahl,et al. "USA-Fat": prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.